TABLE 1

Patients’ Characteristics and Radionuclide Imaging Results: Malignant Nodules

Patient no.	Age (y)	Sex	Histologic type	Size (cm)	FDG		²⁰¹Tl
Patient no.	Age (y)	Sex	Histologic type	Size (cm)	SUV	T/N	ER	DR	RI (%)
1	70	F	BAC	1.2	Neg.	Neg.	Neg.	Neg.	NA
2	51	F	BAC	1.2	Neg.	Neg.	Neg.	Neg.	NA
3*	76	F	BAC	1.7	1.27	2.33	1.30	Neg.	NA
4	69	F	BAC	1.9	Neg.	Neg.	1.75	Neg.	NA
5	78	F	BAC	2.0	Neg.	Neg.	Neg.	1.56	NA
6	76	F	BAC	2.0	Neg.	Neg.	1.39	1.79	28.8
7	54	F	BAC	2.2	Neg.	Neg.	Neg.	Neg.	NA
8	49	F	BAC	2.5	Neg.	Neg.	Neg.	Neg.	NA
9	50	F	BAC	2.6	Neg.	Neg.	Neg.	Neg.	NA
10	63	F	BAC	3.8	2.78	3.86	1.97	2.48	25.9
11	67	M	BAC	4.0	2.14	4.29	1.81	1.64	−9.4
12^†	68	M	Well-diff. AC	1.4	3.86	5.82	1.51	2.59	71.5
13	51	M	Well-diff. AC	1.7	2.03	3.19	1.35	Neg.	NA
14	81	F	Well-diff. AC	1.8	4.52	5.47	1.74	1.83	5.2
15	46	F	Well-diff. AC	1.9	2.32	1.97	Neg.	1.53	NA
16	48	F	Well-diff. AC	2.0	1.78	2.66	1.84	2.20	19.6
17	62	F	Well-diff. AC	2.0	1.24	3.13	1.56	1.56	0
18	49	M	Well-diff. AC	2.4	Neg.	Neg.	1.50	2.62	74.7
19	64	F	Well-diff. AC	3.0	3.25	8.95	2.10	3.02	43.8
20	67	F	Well-diff. AC	3.1	3.71	8.40	1.69	4.02	137.9
21	70	M	Well-diff. AC	3.2	4.41	10.80	2.43	3.81	56.8
22	79	F	Well-diff. AC	4.5	4.48	7.16	2.41	3.60	49.4
23	75	M	Well- to mod. diff. AC	1.8	2.52	2.04	Neg.	1.68	NA
24	65	M	Well- to mod. diff. AC	2.8	1.79	5.39	3.09	3.47	12.3
25^†	68	M	Mod. diff. AC	1.1	2.00	2.17	1.59	Neg.	NA
26	42	F	Mod. diff. AC	1.5	2.64	3.59	Neg.	Neg.	NA
27	47	F	Mod. diff. AC	1.6	2.04	2.46	Neg.	1.83	NA
28	63	M	Mod. diff. AC	1.8	3.81	5.14	Neg.	Neg.	NA
29*	76	F	Mod. diff. AC	1.9	3.76	10.70	1.70	1.63	−4.1
30	72	F	Mod. diff. AC	2.0	1.79	3.75	1.31	1.55	18.3
31	53	F	Mod. diff. AC	2.5	5.31	6.17	1.44	2.18	51.4
32	73	M	Mod. diff. AC	2.8	2.35	4.01	Neg.	1.86	NA
33	53	M	Mod. diff. AC	2.9	5.76	6.60	1.36	2.09	53.7
34	59	F	Mod. diff. AC	3.5	2.12	3.72	1.23	2.32	88.6
35	59	F	Mod. diff. AC	3.5	7.06	8.26	Neg.	Neg.	NA
36	64	M	Mod. diff. AC	3.6	5.94	16.80	2.46	2.97	20.7
37	68	M	Mod. diff. AC	3.8	4.87	9.44	2.21	2.45	10.9
38	75	M	Mod. diff. AC	4.9	6.05	12.80	3.86	4.24	9.8
39	85	M	Poorly diff. AC	0.8	2.11	6.65	1.90	3.87	103.7
40	71	M	Poorly diff. AC	2.5	6.13	5.01	1.44	2.45	70.1
41^‡	50	M	Poorly diff. AC	3.2	5.80	10.58	1.17	Neg.	NA
42	54	M	Poorly diff. AC	4.0	8.29	7.78	1.83	4.48	144.8
43^‡	50	M	Poorly diff. AC	5.2	5.02	9.17	1.84	1.55	−15.8
44	59	M	Poorly diff. AC	5.5	5.97	10.20	1.28	1.47	14.8
45	66	M	SCC	1.5	4.77	4.95	Neg.	1.71	NA
46	75	M	SCC	1.7	3.72	5.05	2.27	2.82	24.2
47	71	M	SCC	2.0	5.30	23.80	2.66	3.31	24.4
48	76	M	SCC	3.0	7.22	12.90	2.91	4.79	64.6
49	64	M	SCC	4.0	6.19	8.96	1.44	1.92	33.3
50	70	M	SCC	6.3	9.74	29.80	3.83	3.54	−7.6
51	73	M	Adeno-SCC	2.7	9.86	16.10	3.37	3.26	−3.3
52	76	M	Adeno-SCC	3.1	7.90	8.21	1.78	2.42	36.0
53	82	F	Large cell carcinoma	1.8	3.26	6.16	1.72	2.42	40.7
54	67	F	Metastatic lung carcinoma	1.5	Neg.	Neg.	Neg.	Neg.	NA

↵*Same patient.
↵^†Same patient.
↵^‡Same patient.
BAC = bronchioloalveolar carcinoma; Neg. = negative; NA = not applicable; diff. = differentiated; AC = adenocarcinoma; mod. or Mod. = moderately; SCC = squamous cell carcinoma; Adeno-SCC = adenosquamous cell carcinoma.